Neurofibromatosis type 2

(redirected from Neurofibromatosis type II)
Also found in: Wikipedia.

Neurofibromatosis type 2 (NF2)

A hereditary condition associated with an increased risk of bilateral acoustic neuromas, other nerve cell tumors and cataracts.
Mentioned in: Acoustic Neuroma
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
Epivatianos, "Localized tongue amyloidosis in a patient with neurofibromatosis type II," Head & Neck Pathology, vol.
The researchers conducted animal studies tracking the effects of celecoxib on the growth of cancer cells from a tumour type known as neurofibromatosis type II (NF2).
They are mostly sporadic but there are a few reports of ganglioneuromas associated with neurofibromatosis type II and multiple endocrinologic neoplasia type II.
Auditory brainstem implantation improves speech recognition in neurofibromatosis type II patients.
In the United States, the ABI is approved for use only in patients 12 years or older with neurofibromatosis type II, an inherited disease that causes a non-malignant brain tumor on the hearing nerve, but it has shown limited effectiveness in adults.
The vestibular schwannomas on bilateral side is associated with neurofibromatosis type II.
Spinal tumours in patients with neurofibromatosis type II: MR imaging study of frequency, multiplicity and variety.
These findings suggested the presence of schwannomas and led to a presumptive diagnosis of neurofibromatosis type II. The patient also developed progressively worsening low back pain and experienced difficulty walking secondary to myelopathy and peripheral neuropathy.
Donna Getz is a member of a family who has been dealing with the effects of neurofibromatosis type II (NF2) for several generations.
Agenesis of internal carotid artery associated with neurofibromatosis type II. AJNR Am J Neuroradiol 1994;15:1184-6.